Back to top
more

Agilent Technologies (A)

(Delayed Data from NYSE)

$127.06 USD

127.06
4,334,339

+2.73 (2.20%)

Updated Jun 18, 2026 04:01 PM ET

After-Market: $127.13 +0.07 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (160 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.

Zacks Equity Research

Medtronic (MDT) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

Medtronic (MDT) delivered earnings and revenue surprises of +3.82% and +1.11%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Clearside Biomedical (CLSD) delivered earnings and revenue surprises of -70.15% and -23.57%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of 0.00% and -0.74%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

MacroGenics (MGNX) delivered earnings and revenue surprises of +156.25% and +157.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Canopy Growth Corporation (CGC) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Canopy Growth (CGC) delivered earnings and revenue surprises of +90.91% and -7.48%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

BioLife Solutions, Inc. (BLFS) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

BioLife Solutions (BLFS) delivered earnings and revenue surprises of +500.00% and +8.73%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Perrigo (PRGO) Q3 Earnings Surpass Estimates

by Zacks Equity Research

Perrigo (PRGO) delivered earnings and revenue surprises of +6.67% and -4.84%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Agilent (A) Down 2.5% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Strength in Network Software Drives Roper: Can the Momentum Sustain?

by Zacks Equity Research

ROP lifts its 2025 outlook as the Network Software and Application Software segments gain from GenAI, cross-sell and strong demand.

Zacks Equity Research

GEHC or A: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

GEHC vs. A: Which Stock Is the Better Value Option?